Results 21 to 30 of about 206,509 (284)

The effect of intravenous ferric carboxymaltose on cardiac reverse remodelling following cardiac resynchronization therapy—the IRON-CRT trial

European Heart Journal, 2021
Aims Iron deficiency is common in heart failure with reduced ejection fraction (HFrEF) and negatively affects cardiac function and structure. The study the effect of ferric carboxymaltose (FCM) on cardiac reverse remodelling and contractile status in ...
Pieter Martens, M. Dupont, Jeroen Dauw, P. Nijst, L. Herbots, P. Dendale, P. Vandervoort, L. Bruckers, W. Tang, W. Mullens   +9 more
semanticscholar   +1 more source

The Use of Machine Learning Algorithms in the Evaluation of the Effectiveness of Resynchronization Therapy

Journal of Cardiovascular Development and Disease, 2022
Background: Cardiovascular disease remains the leading cause of death in the European Union and worldwide. Constant improvement in cardiac care is leading to an increased number of patients with heart failure, which is a challenging condition in terms of
Bartosz Krzowski, Jakub Rokicki, Renata Główczyńska, Nikola Fajkis-Zajączkowska, Katarzyna Barczewska, Mariusz Mąsior, Marcin Grabowski, Paweł Balsam   +7 more
doaj   +1 more source

The effect of cardiac resynchronization on morbidity and mortality in heart failure [PDF]

, 2005
Background: Cardiac resynchronization reduces symptoms and improves left ventricular function in many patients with heart failure due to left ventricular systolic dysfunction and cardiac dyssynchrony.
Cleland, John G.F., Daubert, Jean-Claude, Erdmann, Erland, Freemantle, Nick, Gras, Daniel, Kappenberger, Lukas, Tavazzi, Luigi   +6 more
core   +1 more source

Predictors of clinical outcomes after cardiac resynchronization therapy in patients ≥75 years of age: a retrospective cohort study

BMC Geriatrics, 2019
Background Cardiac resynchronization therapy has been shown to benefit selected patients with heart failure and reduced ejection fraction. Older patients have been underrepresented in randomized trials.
Laure Champ-Rigot, Anne-Laure Cornille, Pierre Ollitrault, Arnaud Pellissier, Mathieu Chequel, Damien Legallois, Paul Milliez   +6 more
doaj   +1 more source

Atrioventricular Node Ablation to Enhance Resynchronization Therapy Response in a Patient With Complete Atrioventricular Block

JACC: Case Reports, 2021
Up to one-third of patients who undergo cardiac resynchronization therapy do not obtain clinical benefit. A systematic approach can identify treatable causes in many nonresponding patients.
Axel Sarrias, MD, Damià Pereferrer, MD, Victor Bazan, MD, PhD, Felipe Bisbal, MD, PhD, Raquel Adeliño, MD, Júlia Aranyó, MD, Francisco Gual, MD, Roger Villuendas, MD, Antoni Bayés-Genís, MD, PhD   +8 more
doaj   +1 more source

Infection and migration incidence of cardiac implantable electrical devices in Japan: Web‐based survey results

Journal of Arrhythmia, 2020
Web‐based survey was conducted for experiences of cardiac implantable electrical device (CIED) infection and migration in Japan. A total of 155 cardiologists’ answer was collected in January, 2018.
Hiroshi Nakajima, Nobuhiro Nishii
doaj   +1 more source

Superresponse to Cardiac Resynchronization Therapy [PDF]

Circulation, 2014
Case presentation : A 55-year-old female patient underwent implantation of a cardiac resynchronization therapy (CRT) defibrillator 6 years ago owing to nonischemic dilated cardiomyopathy. Her left-ventricular (LV) ejection fraction (EF) was 28% before implantation, her LV end-diastolic volume index (EDVI) was 144 mL/m2, and her LV end-systolic volume ...
Steffel, Jan, Ruschitzka, Frank
openaire   +3 more sources

Role of cardiac resynchronization therapy in the development of new-onset atrial fibrillation: A single-center prospective study. [PDF]

, 2012
Albeit several studies examined the association between cardiac resynchronization therapy (CRT) and atrial fibrillation (AF) in heart failure (HF), results are still unclear and quite conflicting.
Cristofaro d', Gaetano Santulli, Massimo Chiariello, Salvatore d'   +3 more
core   +3 more sources

Left cardiac atrioventricular delay and inter-ventricular delay in cardiac resynchronization therapy responder and non-responder

Current Directions in Biomedical Engineering, 2016
Cardiac resynchronization therapy is an established therapy for heart failure patients. The aim of the study was to evaluate electrical left cardiac atrioventricular delay and interventricular desynchronization in sinus rhythm cardiac resynchronization ...
Heinke Matthias, Kühnert Helmut, Heinke Tobias, Tumampos Jonas, Dannberg Gudrun   +4 more
doaj   +1 more source

Evidence that conflict regarding size of haemodynamic response to interventricular delay optimization of cardiac resynchronization therapy may arise from differences in how atrioventricular delay is kept constant. [PDF]

, 2014
Aims: Whether adjusting interventricular (VV) delay changes haemodynamic efficacy of cardiac resynchronization therapy (CRT) is controversial, with conflicting results.
Francis, DP, Hughes, AD, Jones, S, Kanagaratnam, P, Kyriacou, A, Manisty, CH, Mayet, J, Peters, NS, Sohaib, SM, Whinnett, ZI   +9 more
core   +2 more sources